Definium Therapeutics, Inc. DFTX
Nasdaq · XNAS · stock · Medicinal Chemicals & Botanical Products · website · IPO 2015-05-04
Definium Therapeutics, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| CITADEL ADVISORS LLC | 1,489,242 | $28.1M |
| TWO SIGMA INVESTMENTS, LP | 1,201,610 | $22.7M |
| MILLENNIUM MANAGEMENT LLC | 846,896 | $16.0M |
| D. E. Shaw & Co., Inc. | 271,717 | $5.1M |
| Point72 Asset Management, L.P. | 175,490 | $3.3M |
| AQR CAPITAL MANAGEMENT LLC | 57,094 | $1.1M |
Source: SEC EDGAR filings · CIK 0001813814 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.